<p>An anti human interleukin-6 monoclonal antibody, which has a high specificity, as well as a hybridoma producing the same is disclosed. Not more than 4 ng of the monoclonal antibody can reduce the biological activity of 200 pg of human interleukin-6 by 50%.</p>
